Carlos Jiménez-Vicente

9PUBLICATIONS
49CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma.

Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego

|Jan 14, 2025
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.

Jose R Álamo, Lucía Mont-de Torres, Sandra Castaño-Díez

|Jan 08, 2025
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

Alexandra Martínez-Roca, Carlos Jiménez-Vicente, Beatriz Merchán

|Oct 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.

Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti

|Aug 29, 2024
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Francesca Guijarro, Sandra Castaño-Díez, Carlos Jiménez-Vicente

|May 29, 2024
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.

Carlos Jiménez-Vicente, Paola Charry, Sandra Castaño-Diez

Pageof 2

Frequent Collaborators

5 joint publications

Sandra Castaño-Díez

5 joint publications

José Ramón Álamo Moreno

5 joint publications

Jordi Esteve

4 joint publications

Francesca Guijarro